Resumen
This document provides guidance to manufacturers on the minimal considerations for in vitro diagnostic (IVD) medical devices in a public health crisis: - general considerations; - risk reduction; - monitoring the devices’ post-market performance and quality assurance; - implementing a communication system. This document does not supersede the existing traditional regulatory authorization requirements for IVD medical devices available in the marketplace.
Informaciones generales
-
Estado: En desarrolloEtapa: Envío de la prueba a la secretaría o inicio de la votación del FDIS: 8 semanas [50.20]
-
Edición: 1Número de páginas: 13
-
Comité Técnico :ISO/TC 212ICS :11.100.10
- RSS actualizaciones